Previous 10 |
home / stock / vph:cc / vph:cc news
VALEO PHARMA ANNOUNCES LISTING OF CONVERTIBLE DEBENTURES ON TSX Canada NewsWire MONTREAL , April 19, 2022 /CNW Telbec/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, is p...
VALEO PHARMA ANNOUNCES LISTING TO THE TORONTO STOCK EXCHANGE Canada NewsWire The Company's shares and warrants to start trading on March 29th, 2022 MONTREAL , March 28, 2022 /CNW Telbec/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHI...
Toronto, Ontario--(Newsfile Corp. - le 25 mars/March 2022) - At the request of the company the common shares and warrants of Valeo Pharma Inc. will be delisted at market close on March 28, 2022. The securities will continue to trade on the Toronto Stock Exchange. ______________________...
VALEO PHARMA REPORTS ITS FIRST QUARTER 2022 RESULTS AND HIGHLIGHTS Canada NewsWire Q1-22 revenues of $4.2 million , up 128% over Q1-21 Q1-22 gross margins of $1.4 million , up 266% over Q1-21 Public reimbursement secured in key provinc...
VALEO PHARMA SECURES ADDITIONAL PUBLIC REIMBURSEMENT FOR REDESCA™, ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® Canada NewsWire Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia ...
VALEO PHARMA TO HOST FIRST QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST AND ATTEND THE 8TH ANNUAL ALPHANORTH CAPITAL CONFERENCE Canada NewsWire MONTREAL , March 17, 2022 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " o...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million ...
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES Canada NewsWire Record Q2-24 revenues of $14.1 million , up 4% over Q2-23 outpacing revenue softness in several non-core brands Q2-24 adjusted EBITDA loss of $2.5 million compared to $1.7 million fo...